The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...

In a video posted to social media on Tuesday, HHS Secretary Robert F. Kennedy, Jr. claimed that there is a lack of clinical ...

RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though ...

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

HHS Secretary Robert F. Kennedy Jr. says the CDC no longer recommends COVID-19 vaccines for healthy pregnant women & children ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Last week saw Novavax receive full approval from the US Food and Drug Administration (FDA) for its COVID-19 vaccine, but with ...

Moderna MRNA announced that it has submitted a regulatory filing with the FDA seeking approval for an updated version of its ...

Kepler Capital analyst Richard Withagen maintained a Buy rating on Diageo (DGEAF – Research Report) on May 23 and set a price target of p2,700.00. The company’s shares closed ...

The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...

France has detected four cases of the new COVID-19 variant NB.1.8.1 for the first time, Anadolu Ajansi reported. Four cases ...